The Minamata Fishing Cooperative had managed to win small payments of "sympathy money" from the company in 1926 and again in 1943, but after the outbreak of Minamata disease, the fishing situation was becoming critical. Fishing catches had declined by 91% between 1953 and 1957. The Kumamoto prefectural government issued a partial ban on the sale of fish caught in the heavily polluted Minamata Bay – but not an all-out ban, which would have legally obliged it to compensate the fishermen. The fishing cooperative protested against Chisso and angrily forced their way into the factory on 6 August and 12 August, demanding compensation. A committee was set up by Minamata Mayor Todomu Nakamura to mediate between the two sides, but this committee was stacked heavily in the companys favour. On 29 August, the fishing cooperative agreed to the mediation committees proposal, stating: "In order to end the anxiety of the citizens, we swallow our tears and accept". Chisso paid the cooperative ¥20 million (US$183,477 — about US$1.7 million in 2021 value) and set up a ¥15 million ($137,608 — about 1.25 million today) fund to promote the recovery of fishing. Since the change of route of wastewater output in 1958, pollution had spread up and down the Shiranui Sea, damaging fisheries there as well. Emboldened by the success of the small Minamata cooperative, the Kumamoto Prefectural Alliance of Fishing Cooperatives also decided to seek compensation from Chisso. On 17 October, 1,500 fishermen from the alliance descended on the factory to demand negotiations.
Tardive dyskinesia (TD) is a disorder that results in involuntary, repetitive body movements, which may include grimacing, sticking out the tongue, or smacking the lips. Additionally, there may be rapid jerking movements or slow writhing movements. In about 20% of people with TD, the disorder interferes with daily functioning.Tardive dyskinesia occurs in some people as a result of long-term use of dopamine-receptor-blocking medications such as antipsychotics and metoclopramide. These medications are usually used for mental illness but may also be given for gastrointestinal or neurological problems. The condition typically develops only after months to years of use. The diagnosis is based on the symptoms after ruling out other potential causes.Efforts to prevent the condition include either using the lowest possible dose or discontinuing use of neuroleptics. Treatment includes stopping the neuroleptic medication if possible or switching to clozapine. Other medications such as valbenazine, tetrabenazine, or botulinum toxin may be used to lessen the symptoms. With treatment, some see a resolution of symptoms, while others do not.Rates in those on atypical antipsychotics are about 20%, while those on typical antipsychotics have rates of about 30%. The risk of acquiring the condition is greater in older people, for women, as well as patients with mood disorders and/or medical diagnoses receiving antipsychotic medications. The term "tardive dyskinesia" first came into use in 1964. Signs and symptoms
Tardive dyskinesia is characterized by repetitive, involuntary movements.